Widgets for Webmasters
Telik's Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
genengnews.com 8 hrs ago 6 relatedPRNEWSWIRE PALO ALTO, Calif., Aug. 21 /PRNewswire-FirstCall/ -- Telik, Inc. announced today that the lead compounds of its Aurora kinase and VEGFR dual inhibitor program met a significant development milestone. "The ability to...

